Drug companies look to profit from DSM-5 – MarketWatch (blog)

by admin on June 5, 2013

Drug companies look to profit from DSM-5
MarketWatch (blog)
Some Parkinson's disease medications, for example, are already approved for use for restless legs syndrome, which was added to the psychiatric manual. “I would bet that there are a lot of happy people in the restless-leg pharmaceutical industry right

View full post on restless leg syndrome – Google News

Leave a Comment

Previous post:

Next post: